Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance-Reference-Cited by-同舟云学术

Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance

Published:2012-10-30 Issue:3 Volume:1 Page:328-337
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Gohno Tatsuyuki¹,Seino Yuko¹²,Hanamura Toru¹,Niwa Toshifumi¹,Matsumoto Mitsuyo¹³,Yaegashi Nobuo³,Oba Hanako⁴,Kurosumi Masafumi⁴,Takei Hiroyuki⁵,Yamaguchi Yuri²,Hayashi Shin‐ichi¹²⁶

Affiliation:

1. Department of Molecular and Functional Dynamics Graduate School of Medicine Tohoku University Aoba‐ku Sendai 980‐8575 Japan

2. Research Institute for Clinical Oncology Saitama Cancer Center Ina‐machi Saitama 362‐0806 Japan

3. Department of Gynecology Graduate School of Medicine Tohoku University Aoba‐ku Sendai 980‐8575 Japan

4. Department of Pathology Saitama Cancer Center Ina‐machi Saitama 362‐0806 Japan

5. Division of Breast Surgery Saitama Cancer Center Ina‐machi Saitama 362‐0806 Japan

6. Center for Regulatory Epigenome and Disease Graduate School of Medicine Tohoku University Aoba‐ku Sendai 980‐8575 Japan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.41

Reference29 articles.

1. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

2. American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

3. Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

4. Ki67 in breast cancer: prognostic and predictive potential

5. FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a membrane-associated estrogen receptor in breast cancer cells and its contribution to hormone therapy resistance using a novel selective ligand;The Journal of Steroid Biochemistry and Molecular Biology;2020-07

2. Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy;PLOS ONE;2019-05-21

3. High Level of Progesteron Receptor Membrane Component 1 (PGRMC 1) in Tissue of Breast Cancer Patients is Associated with Worse Response to Anthracycline-Based Neoadjuvant Therapy;Hormone and Metabolic Research;2017-07-12

4. Estrogen receptor activation by tobacco smoke condensate in hormonal therapy-resistant breast cancer cells;The Journal of Steroid Biochemistry and Molecular Biology;2017-01

5. Differences in Stemness Properties Associated With the Heterogeneity of Luminal-Type Breast Cancer;Clinical Breast Cancer;2015-04